Skip to content

Effect of Arjuna Kwath and Arogyavardhini vati in management of Medoroga w.s.r Dyslipidemia

Comparative study to evaluate the efficacy of Arjuna Kwath and Arogyavardhini vati in management of Medoroga (Dyslipidemia) A Randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079456
Enrollment
62
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Sponsors

Chaudhary Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Diagnosed and confirmed cases of dyslipidemia based on investigation 2 Patients with any one or more Lakshana of Medoroga 3 Patient above 21 and below 60 years of age either sex who will fulfil the criteria of diagnosis 4 Patients willing and able to participate for trial 5 Patients having controlled Diabetes and Hypertension 6 Patients who are ready to give consent with firm home address and contact number which is readily accessible during course of trial

Exclusion criteria

Exclusion criteria: 1 Patient not willing for trail 2 Patient with total cholesterol more than 400mg/dl or triglyceride more than 300mg/dl or LDL more than 200mg/dl or HDL less than 20mg/dl 3 Patient with Hypertension more than 160/100 mm hg 4 Patient having illness like uncontrolled Diabetes mellitus tuberculosis carcinoma or major illness like liver and renal disorders 5 Patient having past history of Myocardial infarction unstable angina and congestive cardiac failure 6 Patient below 21 years of age and above 60 yrs of age 7 Patient having hypersensitivity to any trail drug and their ingredients 8 Pregnant females and lactating mothers

Design outcomes

Primary

MeasureTime frame
Reduction in the hematological parameters of dyslipidemia Total serum cholesterol less than 200mg/dl Serum Triglycerides less than 150mg/dl LDL cholesterol level below 100 mg/dl HDL cholesterol level above 40mg/dl in men and above 50mg/dl in women VLDL cholesterol level below 30 mg/dl Timepoint: 75 days

Secondary

MeasureTime frame
Improvement in symptoms of Medoroga 1 Kshudra Shwasa-Breathlessness 2 Trishna-Polydipsia 3 Nidraadhikya-Excessive sleep 4 Kshudha Atimatra-Excessive hunger 5 Swedadhikya-Excessive sweating 6 Daurgandhya-Bad odour of body 7 Alpa prana-Fatigue Timepoint: 75 days

Countries

India

Contacts

Public ContactDr Atal Bihari Trivedi

Chaudhary brahm prakash ayurved charak sansthan, Khera Dabar, Najafgarh, New Delhi

abdratal8@gmail.com9958046550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026